AusperBio secures USD 37Mln in series A financing
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, with the goal of achieving functional cure for chronic hepatitis B (CHB) infection, yesterday announced the completion of a $37 million Series A financing round. This round was led by existing investor, InnoPinnacle Fund, with participation from new […]
CycleØ announces acquisition of Biogasclean
CycleØ Group Limited today announces its acquisition of Biogasclean, a leading Danish supplier of biological methanation and desulphurisation systems. A prominent, pan-European biomethane platform, CycleØ develops, builds, owns and operates renewable natural gas (RNG) projects in Europe and Latin America. Ara Partners, a private equity and infrastructure investment firm at the forefront of industrial decarbonisation, provided additional […]
CG Life adds Chris Weber as SVP of strategy
CG Life, a leading integrated agency that blends strategic creative, marketing, digital, and communications with science, has welcomed Chris Weber as the agency’s Senior Vice President of Strategy. Weber brings three decades of healthcare agency experience to the role, where he will be responsible for broadening CG Life’s strategic offering and working closely with clients, especially those […]
Bristol Myers Squibb acquires Karuna Therapeutics
Bristol Myers Squibb and Karuna Therapeutics, Inc. recently announced that they have entered into a definitive merger agreement under which Bristol Myers Squibb has agreed to acquire Karuna for $330.00 per share in cash, for a total equity value of $14.0 billion, or $12.7 billion net of estimated cash acquired. The transaction was unanimously approved […]
Ligandal Inc. Appoints Tushar Nuwal for two leadership roles
Ligandal Inc., an early-stage genetic medicine biotechnology company, announces the appointment of Tushar Nuwal as Chief Operating Officer and Chief Business Officer. Mr. Nuwal brings 20 years of biopharmaceutical experience, including roles at small and large pharmaceutical companies. “We are elated to welcome Tushar to Ligandal. His experience in negotiating multi-billion-dollar pharmaceutical transactions and his […]
Massive Bio and CureMatch Partner to provide AI powered cancer treatment
Massive Bio, an AI-powered platform connecting patients with clinical trials and CureMatch, a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision medicine support for oncology, and have announced a transformative partnership aimed at revolutionizing cancer treatment through advanced genomics, artificial intelligence, and expansive clinical trial accessibility. Massive Bio and CureMatch will leverage […]
Pharmatech Associates names Sireesha Yadlapalli as CEO
The Board of Directors of Pharmatech Associates yesterday announced the appointment of Sireesha Yadlapalli as chief executive officer, effective June 5, 2023. Ms. Yadlapalli will succeed Bikash Chatterjee, who will remain with the organization as President and chief science officer. Yadlapalli brings industry and regulatory experience to Pharmatech gained during her over 20-year career in the […]
Acurex Biosciences welcomes Dr. Robert Booth to its Board of Directors
Acurex Biosciences Corporation, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces the appointment of renowned biopharmaceutical industry leader Dr. Robert Booth to its Board of Directors. Dr. Booth, distinguished for his invaluable contributions to the biopharmaceutical industry, brings over 30 years of experience in drug discovery, development, and executive leadership. […]
KBI Biopharma and Selexis SA announces J.D. Mowery as CEO
KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, recently announced the appointment of J.D. Mowery as Chief Executive Officer (CEO). Widely respected as an innovative biotech leader with a nearly 25-year track record of successfully inspiring colleagues and building organizations, J.D. will lead KBI and Selexis into the next chapter of […]
Cognizant collaborates with Boehringer Ingelheim to accelerate the medicinal therapies development
Cognizant announced it is working with Boehringer Ingelheim, one of the leading research-driven biopharmaceutical company, to advance the speed and quality of medicinal therapy development. Leveraging the Veeva Development Cloud, Cognizant will help Boehringer Ingelheim to unify medicinal development processes and data into a connected technology ecosystem, enhancing collaboration across clinical, regulatory, and quality functions. “Achieving […]
